24 Jun 2026
Real-world data (RWD) is quickly becoming a strategic engine for biopharma innovation, offering a more complete view of patient outcomes beyond traditional clinical trials. As highlighted in an interview with Fierce Pharma and Dan Jacob, vice president and general manager of Real-World Data Solutions at Labcorp, these diverse data sources can be transformed into real-world evidence to drive faster, more informed decision-making.
Jacob emphasizes that the value of RWD lies in connecting high-quality, trusted data to unlock actionable insights. This enables biopharma companies to accelerate development, identify new opportunities and improve outcomes at scale.
Looking ahead, Jacob points to advanced analytics, AI and integrated biomarker data as key to unlocking the next wave of innovation. With a focus on curated data and strong partnerships, Labcorp is helping power a more connected, insight-driven future.
Watch the full interview on Fierce Pharma.